Key Events This Week
30 Mar: Lower circuit hit amid heavy selling pressure (₹27.05)
1 Apr: Upper circuit hit on strong buying interest (₹28.05)
2 Apr: Marginal gain with subdued volume (₹29.06)
3 Apr: Week closes at ₹29.06, up 2.29% vs Sensex down 0.29%

Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-04-02 10:10:16Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-04-01 10:00:09At Rs 28.50, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Lower Circuit With 4.92% Loss — Sellers Queue, No Buyers in Sight
2026-03-30 15:00:05At Rs 27.05, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 4.92% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news articleMangalam Drugs Falls 4.60%: Circuit Hits and Volatility Define the Week
2026-03-28 17:05:19
Key Events This Week
23 Mar: Stock declines 1.41% amid broad market sell-off
24 Mar: Hits upper circuit at Rs.30.29, surging 4.16%
25 Mar: Recovers modestly, closing flat at Rs.29.36 (+1.14%)
27 Mar: Plunges to lower circuit, closing at Rs.28.41 (-3.24%)
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March 2026
06-May-2026 | Source : BSEMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board meeting to be held on 14th May 2026 inter-alia to approve Audited Financial results (Standalone & Consolidated)of the Company for the period ended 31st March 2026
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
29-Apr-2026 | Source : BSEThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Shree Kishoriju Trading and Investments Pvt Ltd
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
29-Apr-2026 | Source : BSEThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Aditya Ramniwas Dhoot
Corporate Actions
14 May 2026
Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17
No Splits history available
No Bonus history available
No Rights history available









